Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Champignon Brands Inc. (SHRM.CN)

Champignon Brands Inc. (SHRM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
Champignon Provides Update on Disclosure Review

Champignon Brands Inc. (CSE: SHRM) (the "Company") continues to work with the British Columbia Securities Commission (the "Commission") to address an ongoing continuous disclosure review. Since the review...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

, /PRNewswire/ -- Investors are seeing big opportunity in psychedelics based upon the numbers that the nascent cannabis industry has been putting up… after all, last year, worldwide sales of legal cannabis...

PSYC : 0.0096 (-4.95%)
MMEDF : 0.9800 (-4.85%)
SRNE : 8.28 (+5.48%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
RVV.CN : 0.235 (-6.00%)
RVVTF : 0.1810 (-3.05%)
Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

Champignon Brands Inc. (CSE: SHRM) (the "Company" or "Champignon") is expanding its rapid-onset treatment service for major depressive disorder ("MDD"). Champignon will offer esketamine for the treatment...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Champignon Announces Regulatory Review

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) announces that it has been selected for a continuous disclosure review by the British Columbia Securities Commission...

SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
REPEAT - Champignon's Dr. McIntyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Champignon's Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
REPEAT - Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, since commencing...

SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, since commencing...

SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
IIROC Trade Resumption - SHRM

Trading resumes in:

SHRM.CN : 0.890 (+3.49%)
Champignon Announces Closing of $15 Million Bought Deal Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
IIROC Trading Halt - SHRM

The following issues have been halted by IIROC:

SHRM.CN : 0.890 (+3.49%)
Recent Studies Indicating CBD may be Better Therapy for Treating Anxiety Than Medical Marijuana

, /PRNewswire/ -- Researchers have been looking at more and more uses for medical marijuana in recent years. Marijuana can affect the body in many ways beyond just getting the user high. The high feeling...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
RTSL : 0.8700 (+6.49%)
CGC : 20.30 (+4.16%)
WEED.TO : 26.62 (+3.98%)
OGI : 1.2500 (+0.81%)
OGI.TO : 1.62 (-1.82%)
MMEDF : 0.9800 (-4.85%)
Psychedelic-derived Therapies are Just What the Doctor Ordered to Address a Historic Mental Illness Epidemic

, /PRNewswire/ -- While the global death toll caused by the pandemic is well-publicized, a lesser-known side effect of the ongoing pandemic is the rise in mental illness that it has generated. Due to...

SEEL : 0.8155 (+2.21%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
NUMI.VN : 0.380 (-3.80%)
LKYSD : 0.3330 (+17.54%)
JNJ : 145.08 (+0.80%)
MMEDF : 0.9800 (-4.85%)
REPEAT - Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Psychedelic Drugs Market Projected to Reach $6,859.95 Million by 2027

, /PRNewswire/ -- The psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. analyses that the market is growing with a CAGR of 16.3% in the forecast period...

PSYC : 0.0096 (-4.95%)
SHRM.CN : 0.890 (+3.49%)
BOSS.CN : 0.090 (-5.26%)
MOTA.CN : 0.165 (-2.94%)
SHRMF : 0.4120 (-1.90%)
BOSQF : 0.0712 (-1.39%)
MMEDF : 0.9800 (-4.85%)
PEMTF : 0.0660 (unch)
Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

, /PRNewswire/ --  Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to predicted to hit after the lockdown...

JNJ : 145.08 (+0.80%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.4120 (-1.90%)
LLY : 141.65 (+0.24%)
NUMI.VN : 0.380 (-3.80%)
LKYSD : 0.3330 (+17.54%)
MMEDF : 0.9800 (-4.85%)
BGHM : 0.4600 (+12.20%)
Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services

Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announces...

SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)
Psychedelics Begin Gradual Climb to Medical Status

, /PRNewswire/ -- The fast pace of technological development in the biotechnology industry and the shifting market demands require continuous innovation. This, in turn, puts pressure on companies to invest...

NUMI.VN : 0.380 (-3.80%)
LKYSD : 0.3330 (+17.54%)
MMEDF : 0.9800 (-4.85%)
SHRMF : 0.4120 (-1.90%)
SHRM.CN : 0.890 (+3.49%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar